One last question: what happens if I stop taking Ozempic / Wegovy / Mounjaro
Originally developed as a GLP-1 receptor agonist for managing type 2 diabetes, semaglutide has gained tremendous popularity as a weight loss aid under brand names like Ozempic and Wegovy
Bibcode:2025PNAS..12213811M
If you have been struggling to lose weight through traditional methods and are looking for a non-surgical solution , this medication may be right for you
In a separate study , published in JAMA in August 2025, the same researchers found that, across ages, GLP-1s were associated with lower risk of some obesity-related cancers, such as endometrial, ovarian, and meningioma cancers, but with an increased risk of kidney cancer, and nonsignificant changes for several other cancers
The side effect burden is manageable, and the weight loss is clinically meaningful